表示崩れを起こしている方は、ブラウザの拡張機能の「広告ブロックのプラグイン」が原因の可能性がございます。
お手数おかけしますが、「広告ブロックのプラグイン」をOFFにしていただき、読み込みをお試しください。

アドテック東京

20th - 21st, October 2022
@ TOKYO MIDTOWN
& THE RITZ-CARLTON

SPEAKERS

ad:tech appearance count icon:ad:tech appearance count

Hardy Ts Kagimoto
Hardy Ts Kagimoto New
HEALIOS K.K.
MD, Chairman and CEO

Dr. Tadahisa “Hardy” Kagimoto, MD, is the Founder, Chairman and CEO of Healios K.K., a biotechnology company listed on the Tokyo Stock Exchange market Growth. Healios has grown into a world leader in the development of innovative, engineered iPSC derived therapies and leads the development of stem cell derived regenerative therapies to treat major areas of unmet medical need, including solid tumors, ischemic stroke, and acute respiratory distress syndrome. Prior to founding Healios, Dr. Kagimoto founded and ran as President and CEO Aqumen Biopharmaceuticals K.K., a biotechnology company that developed the de facto standard adjuvant used in eye surgery on a worldwide basis. Prior to founding Aqumen, Dr. Kagimoto was a clinical ophthalmologist after graduated from Kyushu University School of Medicine.

Session

10/21

[ CT-13] Technology enabling us to live fulfilling lives​